EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Long-Term Outcomes of Aspirin vs. Clopidogrel After PCI in High-Risk Patients With Cardiovascular Comorbidities: A Post Hoc Analysis of the HOST-EXAM Extended Trial

Huijin Lee iD, Jeehoon Kang iD, Doyeon Hwang iD, Kyung Woo Park iD, Han-Mo Yang iD, Hyun-Jae Kang iD, Jung-Kyu Han iD, Eun-Seok Shin iD, Bon-Kwon Koo iD, Hyo-Soo Kim iD

Korean Circulation Journal · 2026 · 56 (8) · 680

DOI: 10.4070/kcj.2025.0272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Korean Circulation Journal, 2026. Verfasst von Huijin Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Patient-Centered Clinical Research Coordinating Center, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVES: The HOST-EXAM Extended trial demonstrated the long-term benefits of clopidogrel over aspirin monotherapy following dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). This sub-study evaluated these therapies in patients with and without previous cardiovascular disease (CVD). METHODS: A total of 5,438 patients were randomized to aspirin (100 mg daily) or clopidogrel (75 mg daily) monotherapy. Previous CVD was defined as previous myocardial infarction, cerebrovascular accident, or peripheral artery disease, present in 1,137 patients; 4,301 had no CVD. The primary endpoint was a composite of all-cause death, non-fatal myocardial infarction, stroke, readmission due to ACS, and major bleeding (Bleeding Academic Research Consortium [BARC] type 3 or 5). Secondary endpoints included thrombotic and any bleeding events (BARC type ≥2). Median follow-up was 5.8 years. RESULTS: The primary endpoint occurred more frequently in patients with previous CVD than in those without (18.1% vs. 13.7%, hazard ratio [HR], 1.045; 95% confidence interval [CI], 1.037-1.054; p

Schlagwörter

Stichwörter der Autor:innen

Cardiovascular diseases/historyCoronary artery diseasePercutaneous coronary interventionPlatelet aggregation inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Korea.
  • Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Korea. medikang@snu.ac.kr.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. hanname@snu.ac.kr.
  • Department of Internal Medicine, Ulsan University Hospital, Ulsan, Korea.

ORCID-Profile: Huijin Lee, Jeehoon Kang, Doyeon Hwang, Kyung Woo Park, Han-Mo Yang, Hyun-Jae Kang, Jung-Kyu Han, Eun-Seok Shin, Bon-Kwon Koo, Hyo-Soo Kim

Förderung

  • Patient-Centered Clinical Research Coordinating Center
  • Ministry of Health and Welfare

Zitieren

APA

Lee, H., Kang, J., Hwang, D., Park, K. W., Yang, H. M., Kang, H. J., Han, J. K., Shin, E. S., Koo, B. K., & Kim, H. S. (2026). Long-Term Outcomes of Aspirin vs. Clopidogrel After PCI in High-Risk Patients With Cardiovascular Comorbidities: A Post Hoc Analysis of the HOST-EXAM Extended Trial. Korean Circulation Journal, 56(8), 680. https://doi.org/10.4070/kcj.2025.0272

Vancouver

Lee H, Kang J, Hwang D, Park KW, Yang HM, Kang HJ, et al. Long-Term Outcomes of Aspirin vs. Clopidogrel After PCI in High-Risk Patients With Cardiovascular Comorbidities: A Post Hoc Analysis of the HOST-EXAM Extended Trial. Korean Circulation Journal. 2026;56(8):680. doi:10.4070/kcj.2025.0272

BibTeX
@article{Lee2026,
  author = {Lee, Huijin and Kang, Jeehoon and Hwang, Doyeon and Park, Kyung Woo and Yang, Han-Mo and Kang, Hyun-Jae and Han, Jung-Kyu and Shin, Eun-Seok and Koo, Bon-Kwon and Kim, Hyo-Soo},
  title = {Long-Term Outcomes of Aspirin vs. Clopidogrel After PCI in High-Risk Patients With Cardiovascular Comorbidities: A Post Hoc Analysis of the HOST-EXAM Extended Trial},
  journal = {Korean Circulation Journal},
  year = {2026},
  volume = {56},
  number = {8},
  pages = {680},
  doi = {10.4070/kcj.2025.0272}
}
Kostenlos starten →